ADAMTS9 and breast carcinoma: Consistently, ADAMTS9 was highly expressed in normal human mammary epithelial cell lines (HMEpC), but greatly reduced or completely silenced in multiple breast carcinoma cell lines (6/8, 75%; Fig. 1C).